BSP Spring Meeting 2024
Schedule : Back to Hannah Asiki
Poster
134

Exploring the mode of action of anti-leishmanial natural product analogues

Authors

H Asiki2; Y Biddick3; A Sozanschi3; M Amaral1; E Levatti1; R Wheeler2; EA Anderson3; A Tempone11 Butantan Institute, Brazil;  2 Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, UK;  3 Chemistry Research Laboratory, University of Oxford, UK

Discussion

The dehydrodieugenol family of natural products has specific activity against all Leishmania species tested.1, 2 We have developed an active analogue with both cross-linking and click capabilities which allows access to various techniques for target identification including whole cell localisation and photo-affinity protein pull-downs. Using L. mexicana for our investigations, we demonstrate mitochondrial localisation using both fluorescence light microscopy and transmission electron microscopy.

The ascididemin family of natural products also shows promise as an antiparasitic, having activity against P. falciparum and various Trypanosomes,3 although little is known about its mode of action. We have developed a range of analogues which are highly potent against L. infantum, L. mexicana, and T. cruzi. SAR knowledge from these analogues is a first step towards introducing a handle that can be used for bioorthogonal labelling. Additionally, this family shows metal ion binding capabilities which could contribute to compound mode of action.

Finally, we have explored the benzyltetrahydroisoquinoline alkaloids as antiparasitics. By synthesising a range of natural products and related analogues, we show good antiparasitic activity against L. infantum, L. mexicana, and T. cruzi.4 We combine cell biology techniques such as monitoring cell cycle interruption, changed morphology and dsDNA damage to reveal that kinetoplast disruption likely plays a key role in the mode of action for this compound family.

These natural product families each have unique and varied chemical structures, allowing us to discover interesting and potentially novel modes of action against Leishmania.

References


1. Grecco, S. S.; Costa-Silva, T. A.; Sousa, F. S.; Cargnelutti, S. B.; Umehara, E.; Mendonça, P. S.; Tempone, A. G.; Lago, J. H. G. Journal of Venomous Animals and Toxins including Tropical Diseases 2018, 24 (1), 27.

2. Amaral, M.; Asiki, H.; Sear, C. E.; Singh, S.; Pieper, P.; Haugland, M. M.; Anderson, E. A.; Tempone, A. G. RSC Medicinal Chemistry 2023, 14 (7), 1344-1350.

3. Copp, B. R.; Kayser, O.; Brun, R.; Kiderlen, A. F. Planta Med 2003, 69 (6), 527-531

4. Sozanschi, A.; Asiki, H.; Amaral, M.; de Castro Levatti, E. V.; Tempone, A. G.; Wheeler, R. J.; Anderson, E. A. JACS Au 2024, 4 (2), 847-854.

Hosted By

British Society for Parasitology (BSP)

We are science based Charitable Incorporated Organisation

Get the App

Get this event information on your mobile by
going to the Apple or Google Store and search for 'myEventflo'
iPhone App
Android App
www.myeventflo.com/2520